Archive Newsletter

81. 09.10.25 -- Today's Hit: Analytical Solutions, Enabling Faster, Data-Driven Drug Development 9/10/2025

    09/10/25 Cell & Gene Newsletter

82. 09.10.25 -- Barriers, Breakthroughs, And Building Access In Pediatric CGTs With Bambi Grilley, Ph.D. 9/10/2025
    09/10/25 Cell & Gene Newsletter
83. 09.09.25 -- STREAM Edition: Revolutionizing Cell Therapy Manufacturing With AI 9/9/2025
    09/09/25 Cell & Gene Newsletter
84. 09.09.25 -- Precigen Secures FDA Approval For PAPZIMEOS And Redefines RRP Treatment 9/9/2025
    09/09/25 Cell & Gene Newsletter
85. 09.08.25 -- Biopharma Manufacturing Outsourcing Is Flexible, Not Fractured 9/8/2025
    09/08/25 Cell & Gene Newsletter
86. 09.05.25 -- New Podcast Episodes: Functional Antibody Screening, Safer Stem Cell Therapies, FDA Fridays 9/5/2025
    09/05/25 Cell & Gene Newsletter
87. 09.05.25 -- The Hidden Risk In Cell & Gene Therapy Commercialization 9/5/2025
    09/05/25 Cell & Gene Newsletter
88. 09.04.25 -- Case Studies: Is AI Making Biologics And CGT Outsourcing Smarter? 9/4/2025
    09/04/25 Cell & Gene Newsletter
89. 09.03.25 -- Advancing CAR T Cell Therapy With Logic Gate Engineering 9/3/2025
    09/03/25 Cell & Gene Newsletter
90. 09.02.25 -- STREAM Edition: Key Requirements For Efficient Scale-Up Of Cell Therapy Products, Chapter Four 9/2/2025
    09/02/25 Cell & Gene Newsletter